Literature DB >> 25414821

Delayed uptake and washout of contrast in non-viable infarcted myocardium shown with dynamic computed tomography.

Sebastian Udholm1, Sofie Laugesen1, Peter Agger1, Jesper Hønge1, Morten Smerup1, Nichlas Udholm1, Hans Erik Bøtker1, Morten Bøttcher1.   

Abstract

BACKGROUND: Assessment of ischemic but potentially viable myocardium plays an important role in the planning of coronary revascularization. Until now SPECT, PET, and MRI have been used to identify viable myocardium. Computed tomography (CT) is increasingly used to diagnose coronary atherosclerosis.
OBJECTIVE: To evaluate the feasibility of CT enhancement as a viability marker by investigating myocardial contrast distribution over time in pigs with experimentally induced antero-septal myocardial infarctions.
METHODS: Twelve pigs were subjected to 60 min of balloon occlusion of the left anterior descending artery, followed by removal of the balloon and reperfusion. Four pigs died due to refractory ventricular fibrillation. After 6 weeks, dynamic cardiac CT was performed assessing both wall motion and contrast attenuation. Measurements of attenuation values in Hounsfield units (HU) in the infarct zone and the normal lateral wall were performed at 20 s, and 1, 3, 5, 8 and 12 min after contrast injection.
RESULTS: We found highly significant differences in attenuation values between the two zones at all-time points except t =1 min (ANOVA P=0.85). The normal myocardium showed higher uptake- and washout-rates of contrast than the infarct zone (84±15 vs. 58±8 at 20 s, P=0.0001 and 27±12 vs. 81±13 at 12 min, P=0.0001). Specifically, the ratio between early (20 s) and late (12 min) uptake is a valid marker of viable myocardium. In all animals this ration was above one in the normal zone and below one in the infarct zone.
CONCLUSIONS: Delayed infarct related uptake and washout of contrast shows promise for future clinical application of CT in a combined assessment of coronary atherosclerosis and myocardial viability.

Entities:  

Keywords:  Dynamic computed tomography (CT); attenuation values; myocardial infarct; myocardial ischemia; viability

Year:  2014        PMID: 25414821      PMCID: PMC4221326          DOI: 10.3978/j.issn.2223-3652.2014.09.01

Source DB:  PubMed          Journal:  Cardiovasc Diagn Ther        ISSN: 2223-3652


  29 in total

1.  Heart disease and stroke statistics--2012 update: a report from the American Heart Association.

Authors:  Véronique L Roger; Alan S Go; Donald M Lloyd-Jones; Emelia J Benjamin; Jarett D Berry; William B Borden; Dawn M Bravata; Shifan Dai; Earl S Ford; Caroline S Fox; Heather J Fullerton; Cathleen Gillespie; Susan M Hailpern; John A Heit; Virginia J Howard; Brett M Kissela; Steven J Kittner; Daniel T Lackland; Judith H Lichtman; Lynda D Lisabeth; Diane M Makuc; Gregory M Marcus; Ariane Marelli; David B Matchar; Claudia S Moy; Dariush Mozaffarian; Michael E Mussolino; Graham Nichol; Nina P Paynter; Elsayed Z Soliman; Paul D Sorlie; Nona Sotoodehnia; Tanya N Turan; Salim S Virani; Nathan D Wong; Daniel Woo; Melanie B Turner
Journal:  Circulation       Date:  2011-12-15       Impact factor: 29.690

2.  Beyond the P value: The quest for improving health status in patients with ischemic heart disease.

Authors:  Eldrin F Lewis
Journal:  Circulation       Date:  2010-10-11       Impact factor: 29.690

3.  Assessment of myocardial perfusion and viability from routine contrast-enhanced 16-detector-row computed tomography of the heart: preliminary results.

Authors:  Konstantin Nikolaou; Javier Sanz; Michael Poon; Bernd J Wintersperger; Bernd Ohnesorge; Teresa Rius; Zahi A Fayad; Maximilian F Reiser; Christoph R Becker
Journal:  Eur Radiol       Date:  2005-03-18       Impact factor: 5.315

4.  Contrast-enhanced multidetector computed tomography viability imaging after myocardial infarction: characterization of myocyte death, microvascular obstruction, and chronic scar.

Authors:  Albert C Lardo; Marco A S Cordeiro; Caterina Silva; Luciano C Amado; Richard T George; Anastasios P Saliaris; Karl H Schuleri; Veronica R Fernandes; Menekhem Zviman; Saman Nazarian; Henry R Halperin; Katherine C Wu; Joshua M Hare; Joao A C Lima
Journal:  Circulation       Date:  2006-01-24       Impact factor: 29.690

5.  Myocardial viability: fluorine-18-deoxyglucose positron emission tomography in prediction of wall motion recovery after revascularization.

Authors:  M J Knuuti; M Saraste; P Nuutila; R Härkönen; U Wegelius; A Haapanen; J Bergman; M Haaparanta; T Savunen; L M Voipio-Pulkki
Journal:  Am Heart J       Date:  1994-04       Impact factor: 4.749

6.  Relationship of MRI delayed contrast enhancement to irreversible injury, infarct age, and contractile function.

Authors:  R J Kim; D S Fieno; T B Parrish; K Harris; E L Chen; O Simonetti; J Bundy; J P Finn; F J Klocke; R M Judd
Journal:  Circulation       Date:  1999-11-09       Impact factor: 29.690

7.  Reliable noninvasive coronary angiography with fast submillimeter multislice spiral computed tomography.

Authors:  Koen Nieman; Filippo Cademartiri; Pedro A Lemos; Rolf Raaijmakers; Peter M T Pattynama; Pim J de Feyter
Journal:  Circulation       Date:  2002-10-15       Impact factor: 29.690

8.  Improved outcome after coronary bypass surgery in patients with ischemic cardiomyopathy and residual myocardial viability.

Authors:  P R Pagley; G A Beller; D D Watson; L W Gimple; M Ragosta
Journal:  Circulation       Date:  1997-08-05       Impact factor: 29.690

Review 9.  Noninvasive imaging of myocardial viability: current techniques and future developments.

Authors:  Katherine C Wu; João A C Lima
Journal:  Circ Res       Date:  2003-12-12       Impact factor: 17.367

10.  Results of coronary artery surgery in patients with poor left ventricular function (CASS).

Authors:  E L Alderman; L D Fisher; P Litwin; G C Kaiser; W O Myers; C Maynard; F Levine; M Schloss
Journal:  Circulation       Date:  1983-10       Impact factor: 29.690

View more
  1 in total

Review 1.  Delayed enhancement cardiac computed tomography for the assessment of myocardial infarction: from bench to bedside.

Authors:  Gaston A Rodriguez-Granillo
Journal:  Cardiovasc Diagn Ther       Date:  2017-04
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.